Administration of G-CSF into the AIDS patients increases the fungicidal activity and decreases the risk of infection (Vecchiarelli et al. 1995), which is associated with the enhanced leukotrienes from neutrophils upon G-CSF therapy (Coffey et al. 1998). The gene discussed is CSF3; the disease is infection.